Publications (septembre 2022 à mars 2023)

Les membres de notre Département ont contribué à 54 publications indexées dans PubMed entre septembre 2022 et mars 2023. Voici la liste complète.



  1. Zani F, Blagih J, Gruber T, Buck MD, Jones N, Hennequart M, Newell CL, Pilley SE, Soro-Barrio P, Kelly G, Legrave NM, Cheung EC, Gilmore IS, Gould AP, Garcia-Caceres C, Vousden KH. The dietary sweetener sucralose is a negative modulator of T cell-mediated responses. 2023;615(7953):705-711


  1. Chesney TR, Wong C, Tricco AC, Wijeysundera DN, Ladha KS, Kishibe T, Dubé S, Puts MTE, Alibhai SMH, Daza JF. Frailty assessment tools for use by surgeons when evaluating older adults prior to surgery: a scoping review protocol. BMJ Open. 2022;12(7):e061951.


  1. Dubé S, Alibhai SMH. Frailty After Cancer Surgery Among Older Adults: A Geriatric Oncology Perspective. J Natl Compr Canc Netw. 2022;20(11):1276-1278.


  1. Al Khaldi M, Fellouah M, Drolet P, Côté J, Trilling B, Brind’Amour A, Dugas A, Tremblay JF, Fortin S, De Guerké L, Auclair MH, Dubé P, Soucisse M, Sideris L. The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Curr Oncol. 2022;29(12):9314-9324.


  1. Alenezi WM, Fierheller CT, Serruya C, Revil T, Oros KK, Subramanian DN, Bruce J, Spiegelman D, Pugh T, Campbell IG, Mes-Masson AM, Provencher D, Foulkes WD, Haffaf ZE, Rouleau G, Bouchard L, Greenwood CMT, Ragoussis J, Tonin PN. Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. Front Oncol. 2023;13:1111191.


  1. Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I, Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata S, Scambia G, Monk BJ. Endometrial carcinosarcoma. Int J Gynecol Cancer. 2023;33(2):147-174.


  1. Cadoo K, Simpkins F, Mathews C, Liu YL, Provencher D, McCormick C, ElNaggar AC, Altman AD, Gilbert L, Black D, Kabil N, Bennett J, Munley J, Aghajanian C. Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis. Gynecol Oncol. 2022;166(3):425-431.


  1. Davidson TM, Lebreton CL, Hendricksen AEW, Atkinson HJ, Larson MC, Oberg AL, Provencher DM, Glaspy JA, Karlan BY, Slamon DJ, Konecny GE, Ray-Coquard IL. Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 2023;170:221-228.


  1. Fierheller CT, Alenezi WM, Serruya C, Revil T, Amuzu S, Bedard K, Subramanian DN, Fewings E, Bruce JP, Prokopec S, Bouchard L, Provencher D, Foulkes WD, El Haffaf Z, Mes-Masson AM, Tischkowitz M, Campbell IG, Pugh TJ, Greenwood CMT, Ragoussis J, Tonin PN. Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene. Genes (Basel). 2023;14(2).


  1. Gilbert L, Oaknin A, Matulonis UA, Mantia-Smaldone GM, Lim PC, Castro CM, Provencher D, Memarzadeh S, Method M, Wang J, Moore KN, O’Malley DM. Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer. Gynecol Oncol. 2023;170:241-247.


  1. L’Espérance K, Grundy A, Abrahamowicz M, Arseneau J, Gilbert L, Gotlieb WH, Provencher D, Koushik A. Alcohol intake and the risk of epithelial ovarian cancer. Cancer Causes Control.


  1. Wong J, Roy SF, Provencher D, Rahimi K. Vulvar Squamous Cell Carcinoma With Sarcomatoid Features are HPV-independent Lesions: A Subset are Also Associated With TP 53-independent Lesions and Radiation Therapy. Int J Gynecol Pathol. 2023;42(2):207-211.


  1. Sauriol A, Carmona E, Udaskin ML, Radulovich N, Leclerc-Desaulniers K, Rottapel R, Oza AM, Lheureux S, Provencher DM, Mes-Masson AM. Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer. Sci Rep. 2023;13(1):3334.


  1. Aubrey C, Pond GR, Helpman L, Vicus D, Elit L, Plante M, Lau S, Kwon JS, Altman AD, Willows K, Feigenberg T, Sabourin J, Samouelian V, Bernard L, Cockburn N, Saunders NB, Piedimonte S, Teo-Fortin LA, Kim SR, Sadeq N, Jang JH, Shamiya S, Nelson G. Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study. Curr Oncol. 2023;30(2):1977-1985.


  1. Jamieson A, Huvila J, Chiu D, Thompson EF, Scott S, Salvador S, Vicus D, Helpman L, Gotlieb W, Kean S, Samouelian V, Köbel M, Kinloch M, Parra-Harran C, Offman S, Grondin K, Irving J, Lum A, Senz J, Leung S, McConechy MK, Plante M, Kommoss S, Huntsman DG, Talhouk A, Gilks CB, McAlpine JN. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. Mod Pathol. 2023;36(4):100085.


  1. Jamieson A, Huvila J, Leung S, Chiu D, Thompson EF, Lum A, Kinloch M, Helpman L, Salvador S, Vicus D, Kean S, Samouelian V, Grondin K, Irving J, Offman S, Parra-Herran C, Lau S, Scott S, Plante M, McConechy MK, Huntsman DG, Talhouk A, Kommoss S, Gilks CB, McAlpine JN. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. Gynecol Oncol. 2023;170:282-289.


  1. Oaknin A, Monk BJ, Vergote I, Cristina de Melo A, Kim YM, Lisyanskaya AS, Samouëlian V, Kim HS, Gotovkin EA, Damian F, Chang CL, Takahashi S, Li J, Mathias M, Fury MG, Ivanescu C, Reaney M, LaFontaine PR, Lowy I, Harnett J, Chen CI, Tewari KS. EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer. Eur J Cancer. 2022;174:299-309.


  1. Thompson EF, Huvila J, Jamieson A, Leung S, Lum A, Offman S, Lytwyn A, Sur ML, Hoang L, Irving J, van der Westhuizen N, Morin C, Bicamumpaka C, Azordegan N, Gougeon F, Ennour-Idrissi K, Senz J, McConechy MK, Aguirre-Hernandez R, Lui V, Kuo C, Bell C, Salisbury T, Lawson J, He E, Wang S, Chiu D, Kean S, Samouëlian V, Salvador S, Gotlieb W, Helpman L, Scott S, Wohlmuth C, Vicus D, Plante M, Talhouk A, Huntsman D, Parra-Herran C, Kinloch M, Grondin K, Gilks CB, McAlpine JN. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification. Mod Pathol. 2022;35(12):1974-1982.


  1. Tinker AV, Dhani NC, Ghatage P, McLeod D, Samouëlian V, Welch SA, Altman AD. A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer. Ther Adv Med Oncol. 2023;15:17588359231157633.


  1. Monk BJ, Tewari KS, Dubot C, Caceres MV, Hasegawa K, Shapira-Frommer R, Salman P, Yañez E, Gümüş M, Hurtado de Mendoza MO, Samouëlian V, Castonguay V, Arkhipov A, Tekin C, Li K, Martin Nguyen A, Monberg MJ, Colombo N, Lorusso D. Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2023;24(4):392-402.


  1. Piedimonte S, Feigenberg T, Drysdale E, Kwon J, Gotlieb WH, Cormier B, Plante M, Lau S, Helpman L, Renaud MC, May T, Vicus D. Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learning. J Surg Oncol. 2022;126(6):1096-1103.



  1. Labrecque AA, Roy S, Young D, Chen SA, Brechenmacher L, Le D, Cooper S, Gibson PS, Clarke AE, Dufour A, Skeith L. Romiplostim drug presence in pregnancy and lactation. 2023.


  1. de Macedo MP, Glanzner WG, Gutierrez K, Currin L, Guay V, Carrillo Herrera ME, da Silva Z, Baldassarre H, McGraw S, Bordignon V. Simultaneous Inhibition of Histone Deacetylases and RNA Synthesis Enables Totipotency Reprogramming in Pig SCNT Embryos. Int J Mol Sci. 2022;23(22).


  1. McGraw S, Kimmins S. Inheritance of epigenetic DNA marks studied in new mouse model. 2023;615(7954):800-802.


  1. Carmant LS, Audibert F, Wavrant S, Thériault K, Codsi E. Impact of Selective Fetal Growth Restriction on Laser Therapy Outcomes in Twin Twin Transfusion Syndrome. Fetal Diagn Ther.


  1. Carmant LS, Boucoiran I, Mathe M, Boutin C, Birca A, Morin L. Prenatal markers of atypical neurodevelopment in children with congenital heart defects. J Matern Fetal Neonatal Med. 2022;35(25):6286-6290.


  1. Boucoiran I, Elwood C, Poliquin V. Time to Optimize Infectious Disease Screening in Pregnancy. J Obstet Gynaecol Can. 2023;45(2):101-102.


  1. Boucoiran I, Kaida A, Blakeley C, Skerritt L, Khan S, Bakombo MD, Greene S, Kennedy VL, Brophy J, Balleny R, Gormley R, Loutfy M, de Pokomandy A. Practices, support and stigma related to infant feeding and postpartum engagement in care among women living with HIV in Canada. AIDS Care. 2023:1-11.


  1. Gorgui J, Atallah A, Boucoiran I, Gomez YH, Bérard A. SARS-CoV-2 vaccine uptake and reasons for hesitancy among Canadian pregnant people: a prospective cohort study. CMAJ Open. 2022;10(4):E1034-e1043.


  1. Khan S, Tsang KK, Brophy J, Kakkar F, Kennedy VL, Boucoiran I, Yudin MH, Money D, Read S, Bitnun A. Canadian Pediatric & Perinatal HIV/AIDS Research Group consensus recommendations for infant feeding in the HIV context. J Assoc Med Microbiol Infect Dis Can. 2023;8(1):7-17.


  1. Leavey K, MacKenzie RK, Faber S, Lloyd VK, Mao C, Wills MKB, Boucoiran I, Cates EC, Omar A, Marquez O, Darling EK. Lyme borreliosis in pregnancy and associations with parent and offspring health outcomes: An international cross-sectional survey. Front Med (Lausanne). 2022;9:1022766.


  1. Schneidman J, Lee T, Sauve L, Brophy J, Bitnun A, Singer J, Money D, Kakkar F, Boucoiran I. Type and timing of antiretroviral therapy during pregnancy: Impact on risk of preterm delivery and small-for-gestational age births in Canada, a retrospective cohort study. Int J Gynaecol Obstet.


  1. Spénard E, Tordjman L, Marrié-Mas AE, Dal Soglio D, Eberle A, Labbé AC, Boucoiran I. Evaluation of a clinical protocol for the management of fever in labor among pregnant women at term: A quality-improvement study. Int J Gynaecol Obstet. 2023;161(1):225-233.


  1. Pagès N, Gorgui J, Wang C, Wang X, Zhao JP, Tchuente V, Lacasse A, Côté S, King S, Muanda F, Mufike Y, Boucoiran I, Nuyt AM, Quach C, Ferreira E, Kaul P, Winquist B, O’Donnell KJ, Eltonsy S, Chateau D, Hanley G, Oberlander T, Kassai B, Mainbourg S, Bernatsky S, Vinet É, Brodeur-Doucet A, Demers J, Richebé P, Zaphiratos V, Bérard A. The Impact of COVID-19 on Maternal Mental Health during Pregnancy: A Comparison between Canada and China within the CONCEPTION Cohort. Int J Environ Res Public Health. 2022;19(19).


  1. Ronzoni S, Boucoiran I, Yudin MH, Coolen J, Pylypjuk C, Melamed N, Holden AC, Smith G, Barrett J. Guideline No. 430: Diagnosis and management of preterm prelabour rupture of membranes. J Obstet Gynaecol Can. 2022;44(11):1193-1208.e1191.


  1. Bujold L, Audibert F, Chaillet N. Optimal Gestational Weight Gain for Women With Obesity. J Obstet Gynaecol Can. 2022;44(11):1143-1152.


  1. Caron L, Fillion A, Giguère Y, Audibert F, Forest JC, Gasse C, Girard M, Laforest G, Guerby P, Bujold E. First-trimester screening for Down syndrome using quadruple maternal biochemical markers. Clin Chem Lab Med.


  1. von Dadelszen P, Audibert F, Bujold E, Bone JN, Sandhu A, Li J, Kariya C, Chung Y, Lee T, Au K, Skoll MA, Vidler M, Magee LA, Piedboeuf B, Baker PN, Lalji S, Lim KI. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations. BMC Res Notes. 2022;15(1):244


  1. Tétu A, Guerby P, Rallu F, Duperron L, Morin V, Bujold E. Mid-trimester microbial invasion of the amniotic cavity and the risk of preterm birth. J Matern Fetal Neonatal Med. 2022;35(21):4071-4074.



  1. Dahdouh EM, Mourad AM, Balayla J, Sylvestre C, Brezina PR, Kutteh WH, Picchetta L, Capalbo A, Garcia-Velasco JA. Update on preimplantation genetic testing for aneuploidy and outcomes of embryos with mosaic results. Minerva Obstet Gynecol.


  1. Dahdouh EM, Balayla J. SARS-CoV-2 vaccines and in vitro fertilization outcomes: so far, so good! Fertil Steril.


  1. Genest G, Banjar S, Almasri W, Beauchamp C, Benoit J, Buckett W, Dzineku F, Gold P, Dahan MH, Jamal W, Jacques Kadoch I, Kadour-Peero E, Lapensée L, Miron P, Shaulov T, Sylvestre C, Tulandi T, Mazer BD, Laskin CA, Mahutte N. Immunomodulation for unexplained recurrent implantation failure: where are we now? 2023;165(2):R39-r60.



  1. Bouteaud J, Shaltout O, Christakis MK, Murtaza F, Wolfman W, Shirreff L. Impact of a 12-minute educational video prior to initial consultation in a Mature Women’s Health and Menopause Clinic. 2022;29(7):856-860.


  1. Brander EP, Keenahan LA, Sangi-Haghpeykar H, Graham M, Dietrich JE. The effect of the rate of increase of estrogen replacement therapy on bone mineral density accrual in young patients with Turner syndrome. J Pediatr Adolesc Gynecol.


  1. Rose M, Jodoin A, Duros S, Sonigo C, Grynberg M, Polak M, da Costa S, Bidet M. Fertility preservation in teenage girls, for non- oncological indications. J Gynecol Obstet Hum Reprod. 2022;51(9):102449.


  1. Jodoin A, Marchand M, Beltrand J. Wolfram syndrome in a young woman with associated hypergonadotropic hypogonadism – A case report. J Pediatr Endocrinol Metab. 2022;35(12):1552-1555.


  1. Le Berre M, Filiatrault J, Reichetzer B, Dumoulin C. Feasibility, acceptability and effects of a group pelvic floor muscle telerehabilitation program to treat urinary incontinence in older women. Digit Health. 2022;8:20552076221123720.


  1. Norman WV, Wilson RD, Francoeur D. The SOGC Supports High-Quality, Accessible Abortion Care. J Obstet Gynaecol Can. 2022;44(9):945-947.


  1. Cacciari LP, Morin M, Mayrand MH, Dumoulin C. Never Too Late to Train: The Effects of Pelvic Floor Muscle Training on the Shape of the Levator Hiatus in Incontinent Older Women. Int J Environ Res Public Health. 2022;19(17).


  1. Cyr MP, Dostie R, Camden C, Dumoulin C, Bessette P, Pina A, Gotlieb WH, Lapointe-Milot K, Mayrand MH, Morin M. Acceptability of multimodal pelvic floor physical therapy to treat dyspareunia after gynecological malignancies: a qualitative study of women’s views and experiences. Int Urogynecol J. 2022:1-13.


  1. Datta GD, Mayrand MH, Glenn BA. Correspondence on « The increasing incidence of stage IV cervical cancer in the USA: what factors are related? » by Francoeur et al. Int J Gynecol Cancer. 2023;33(1):136.


  1. Mailhot-Larouche S, Chauvette V, Bergeron D, Larochelle C, Du Pont-Thibodeau G, Wang H, Cardinal H, Bourdeau I, Auger N, Bureau N, Prat A, Jutras-Aswad D, Madore F, Emeriaud G, Bahig H, Mayrand MH, Tadros R, Parent S, Richebe P, Merhi Y, Nguyen D. University of Montreal’s Clinician-Investigator Program: A 10-Year Descriptive Evaluation. Clin Invest Med. 2022;45(4):E1-10.


  1. Santerre-Baillargeon M, Rosen NO, Vaillancourt-Morel MP, Corsini-Munt S, Steben M, Mayrand MH, Bergeron S. Mediators of change in cognitive-behavioral couple therapy for genito-pelvic pain: Results of a randomized clinical trial. Health Psychol. 2023;42(3):161-171.


  1. Tatar O, Haward B, Zhu P, Griffin-Mathieu G, Perez S, McBride E, Lofters AK, Smith LW, Mayrand MH, Daley EM, Brotherton JML, Zimet GD, Rosberger Z. Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales. Curr Oncol. 2023;30(1):1206-1219.